Clinical Trial Update: Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing interferon alfa with and without isotretinoin for metastatic renal cell carcinoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)
• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Kidney Cancer | Phase 3 | Status: COMPLETED